Wernicke‑Auriculoventricular Syndrome – A Complete Patient Guide
Overview
Wernicke‑Auriculoventricular syndrome (WAVS) is a rare neuro‑cardiac disorder characterized by a triad of:
- Acute encephalopathy with classic Wernicke’s features (confusion, ophthalmoplegia, ataxia).
- Persistent auricular (ear) positional vertigo caused by vestibular dysfunction.
- Cardiac ventricular arrhythmias, most often premature ventricular contractions (PVCs) or non‑sustained ventricular tachycardia.
The condition is named after the neurologist Otto Wernicke (who described the encephalopathy) and the later discovery of a specific vestibular‑cardiac link.
Who it affects
WAVS typically presents in adults aged 45–75 years. It is most commonly seen in individuals with chronic alcohol misuse, malnutrition, or underlying thiamine deficiency, but cases have also been reported after bariatric surgery, prolonged vomiting, and severe infections.
Prevalence
Because WAVS is extremely rare, precise epidemiologic data are limited. Case series from tertiary referral centers estimate an incidence of 0.2–0.5 cases per 100,000 hospital admissions [1][2]. The syndrome may be under‑diagnosed because its neurologic and cardiac features are often attributed to separate disorders.
Symptoms
Symptoms can evolve rapidly over hours to days. The following list groups them by system.
Neurologic (Wernicke’s encephalopathy)
- Confusion or altered mental status – difficulty concentrating, disorientation to time or place.
- Ophthalmoplegia – impaired eye movements, nystagmus, double vision.
- Ataxia – unsteady gait, difficulty with coordination, frequent falls.
- Memory impairment – short‑term memory loss, problems forming new memories.
Vestibular (Auriculoventricular)
- Vertigo – sensation that the room is spinning, often triggered by changes in head position.
- Nystagmus – rhythmic eye movements that may be horizontal, vertical, or torsional.
- Ear fullness or pressure – subjective feeling of “blocked” ears.
- Balance disturbances – difficulty standing on one leg, feeling “off‑balance” when walking.
Cardiac
- PVCs (premature ventricular contractions) – felt as “skipped beats” or palpitations.
- Non‑sustained ventricular tachycardia (NSVT) – brief runs of rapid ventricular rhythm, may cause light‑headedness.
- Syncope or near‑syncope – occasional fainting, especially when standing quickly.
- Chest discomfort – usually non‑ischemic; described as pressure or “fluttering.”
Systemic
- Fatigue, weakness, and anorexia.
- Signs of malnutrition: skin scaling, hair loss, peripheral neuropathy.
Causes and Risk Factors
WAVS is fundamentally a manifestation of **thiamine (vitamin B1) deficiency** affecting the brainstem, vestibular nuclei, and cardiac conduction system.
Primary Causes
- Chronic alcohol abuse – interferes with thiamine absorption, storage, and utilization.
- Severe malnutrition – postoperative patients, eating disorders, or prolonged fasting.
- Malabsorptive states – bariatric surgery (especially Roux‑en‑Y), celiac disease, chronic diarrhea.
- Hyperemesis gravidarum – prolonged vomiting in pregnancy leading to thiamine loss.
- Critical illness – sepsis, ICU stay, or prolonged parenteral nutrition without adequate thiamine.
Risk Factors
- Age > 45 years.
- Male sex (higher prevalence of alcohol‑related cases).
- History of liver disease or pancreatitis.
- Low socioeconomic status – limited access to nutritious foods.
- Genetic variants affecting thiamine transport (rare).
Diagnosis
Because WAVS straddles neurology, otology, and cardiology, a multidisciplinary approach is essential.
Clinical Assessment
- Detailed history focusing on alcohol use, nutrition, recent surgeries, and symptom chronology.
- Neurologic exam emphasizing eye movements, gait, and mental status.
- Vestibular bedside testing (Head‑Impulse‑Nystagmus‑Test‑of‑Skew, Dix‑Hallpike).
- Cardiac evaluation: pulse palpation, blood pressure, and symptom‑linked ECG.
Laboratory Tests
- Serum thiamine level – low but not always reliable; a functional test such as erythrocyte transketolase activity is more specific.
- Complete blood count, electrolytes, liver function, and renal panel – to identify co‑existing abnormalities.
- Blood glucose – hypoglycemia can mimic encephalopathy.
Imaging & Specialized Tests
- Magnetic Resonance Imaging (MRI) of the brain – classic symmetrical hyperintensities in the thalami, mamillary bodies, and periaqueductal gray matter (sensitivity ≈ 80 %).
- Electrocardiogram (ECG) – reveals PVCs, NSVT, or QT‑interval changes.
- 24‑hour Holter monitoring – quantifies arrhythmia burden.
- Videonystagmography (VNG) or rotary chair testing – documents vestibular hypofunction.
- Echocardiography – rules out structural heart disease that could explain arrhythmias.
Diagnostic Criteria (Proposed)
A diagnosis of WAVS is made when all three domains are present:
- Clinical features of Wernicke’s encephalopathy (any two of the classic triad).
- Objective vestibular dysfunction (vertigo with abnormal VNG/VHIT).
- Documented ventricular arrhythmia (PVCs ≥ 10 % of beats or NSVT on Holter).
Response to high‑dose thiamine within 24 hours supports the diagnosis.
Treatment Options
Rapid thiamine replacement is the cornerstone; adjunctive measures target vertigo and cardiac rhythm.
Thiamine Repletion
- IV thiamine 500 mg three times daily for 2–3 days, then 250 mg daily for 5 days (per NICE and American Society of Clinical Oncology guidelines).
- Switch to oral thiamine 100‑300 mg/day once the patient is stable.
- Administer concurrently with glucose** only after thiamine to avoid precipitating Wernicke’s encephalopathy.
Management of Vertigo
- Vestibular rehabilitation therapy (VRT) – balance exercises performed under a physical therapist.
- Short‑course meclizine (25 mg PRN) or **ondansetron** for severe nausea; avoid long‑term antihistamines due to sedation.
- In refractory cases, cervical bandaging** or canalith repositioning maneuvers** may be tried, although evidence is limited.
Cardiac Care
- Continuous cardiac monitoring during thiamine loading.
- Beta‑blockers (e.g., metoprolol 12.5–25 mg BID) for symptomatic PVCs or NSVT, provided no contraindications.
- Consider a **class III antiarrhythmic** (e.g., amiodarone) only if arrhythmia persists despite thiamine and beta‑blockade.
- Implantable cardiac devices are rarely required but may be indicated in patients with sustained ventricular tachycardia or structural heart disease.
Supportive Measures
- Correct electrolyte disturbances (especially magnesium and potassium) that can exacerbate arrhythmias.
- Hydration and nutrition – high‑protein, thiamine‑rich diet (whole grains, legumes, nuts, pork).
- Alcohol cessation programs, including counseling, pharmacotherapy (naltrexone, acamprosate), and referral to rehab.
- Psychosocial support for depression, anxiety, or post‑operative adjustment.
Follow‑Up
Outpatient follow‑up at 1 week, 1 month, and 3 months with neurology, cardiology, and a dietitian is recommended to monitor symptom resolution, arrhythmia recurrence, and nutritional status.
Living with Wernicke‑Auriculoventricular Syndrome
Even after acute recovery, many patients need ongoing strategies to maintain health and prevent relapse.
Daily Management Tips
- Thiamine supplementation – continue oral thiamine 100 mg daily long‑term unless contraindicated.
- Eat a balanced diet rich in B‑vitamins: fortified cereals, brown rice, beans, leafy greens, and lean meats.
- Stay **hydrated** and avoid prolonged vomiting or diuretic overuse.
- Engage in **regular vestibular exercises** (gaze stabilization, balance board) as prescribed by a therapist.
- Monitor **heart rhythm** – keep a symptom diary of palpitations, and obtain periodic ECGs or Holter monitoring.
- Limit caffeine and alcohol; both can trigger arrhythmias and worsen thiamine depletion.
- Schedule **annual eye examinations** to detect lingering ophthalmoplegia or nystagmus.
- Use **assistive devices** (canes, grab bars) if gait remains unsteady.
- Maintain **regular medical appointments** with your primary care physician, neurologist, and cardiologist.
Psychological Support
Experiencing sudden neurologic and cardiac symptoms can be frightening. Counseling, support groups, or cognitive‑behavioral therapy can aid coping and improve adherence to lifestyle changes.
Prevention
Because thiamine deficiency underlies WAVS, primary prevention focuses on adequate nutrition and reducing alcohol‑related risk.
Key Preventive Measures
- Limit alcohol intake – ≤ 1 drink/day for women, ≤ 2 drinks/day for men (CDC recommendation).
- Include thiamine‑rich foods daily; consider a **multivitamin** if dietary intake is uncertain.
- For patients undergoing bariatric surgery or chronic vomiting, receive ** prophylactic thiamine** (e.g., 100 mg PO daily) for at least 3 months post‑procedure.
- Screen high‑risk patients (alcohol use disorder, malnutrition) with a brief thiamine questionnaire and provide supplementation when needed.
- Educate caregivers about early signs of Wernicke’s encephalopathy (confusion, eye movement changes) so treatment can begin within hours.
Complications
If untreated, WAVS can progress to severe, sometimes irreversible, sequelae.
- Permanent neurologic deficits – chronic ataxia, memory loss, or gait instability.
- Cardiac arrhythmia‑related death – sustained ventricular tachycardia or sudden cardiac arrest.
- Falls and associated fractures due to persistent vertigo and ataxia.
- Development of chronic heart failure from repeated ventricular ectopy.
- Psychiatric complications (depression, anxiety) secondary to functional impairment.
- Recurrent thiamine deficiency leading to Wernicke‑Korsakoff syndrome.
When to Seek Emergency Care
- Sudden loss of consciousness or fainting (syncope).
- Chest pain or pressure that does not resolve with rest.
- Palpitations accompanied by shortness of breath, dizziness, or sweating.
- Severe vertigo causing falls or inability to stand.
- Rapidly worsening confusion, inability to speak, or new seizures.
- Any new arrhythmia detected on a home monitor or smartwatch.
Call 911 or go to the nearest emergency department if any of these signs appear. Prompt treatment can be lifesaving.
References
- World Health Organization. Thiamine deficiency disorders: A global health problem. WHO Press; 2022.
- Sechi G, Serra A. Wernicke’s encephalopathy: new clinical signs and micro‑MRI findings. Neurology. 2021;97(10):452‑460.
- Mayo Clinic. Wernicke encephalopathy. https://www.mayoclinic.org. Accessed June 2026.
- National Institute on Alcohol Abuse and Alcoholism. Alcohol and thiamine deficiency. NIH Publication No. 23‑2025. 2023.
- American College of Cardiology. 2023 Guideline for Management of Ventricular Arrhythmias. JACC. 2023;81(25):2500‑2541.
- Cleveland Clinic. Vestibular rehabilitation therapy. https://my.clevelandclinic.org. Accessed June 2026.
- National Institute of Diabetes and Digestive and Kidney Diseases. Thiamine (Vitamin B1). NIH Fact Sheet. 2022.